Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)

Name: Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)
Published: 2026
License: Public Domain

The Affiliated Hospital of Xuzhou Medical University · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

dlbcl - diffuse large b cell lymphoma, orelabrutinib, dlbcl, auto-hsct, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)

Related documents